Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING).
Pettorruso M, Guidotti R, d'Andrea G, De Risio L, D'Andrea A, Chiappini S, Carullo R, Barlati S, Zanardi R, Rosso G, De Filippis S, Di Nicola M, Andriola I, Marcatili M, Nicolò G, Martiadis V, Bassetti R, Nucifora D, De Fazio P, Rosenblat JD, Clerici M, Maria Dell'Osso B, Vita A, Marzetti L, Sensi SL, Di Lorenzo G, McIntyre RS, Martinotti G; REAL-ESK Study Group. Pettorruso M, et al. Among authors: marcatili m. Psychiatry Res. 2023 Sep;327:115378. doi: 10.1016/j.psychres.2023.115378. Epub 2023 Jul 28. Psychiatry Res. 2023. PMID: 37574600 Free article.
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.
Martinotti G, Dell'Osso B, Di Lorenzo G, Maina G, Bertolino A, Clerici M, Barlati S, Rosso G, Di Nicola M, Marcatili M, d'Andrea G, Cavallotto C, Chiappini S, De Filippis S, Nicolò G, De Fazio P, Andriola I, Zanardi R, Nucifora D, Di Mauro S, Bassetti R, Pettorruso M, McIntyre RS, Sensi SL, di Giannantonio M, Vita A; REAL-ESK Study Group. Martinotti G, et al. Among authors: marcatili m. Bipolar Disord. 2023 May;25(3):233-244. doi: 10.1111/bdi.13296. Epub 2023 Jan 18. Bipolar Disord. 2023. PMID: 36636839 Free article.
The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from different mental disorders: An observational retrospective study.
Caldiroli A, Capuzzi E, Tringali A, Tagliabue I, Turco M, Fortunato A, Sibilla M, Montana C, Maggioni L, Pellicioli C, Marcatili M, Nava R, Crespi G, Colmegna F, Buoli M, Clerici M. Caldiroli A, et al. Among authors: marcatili m. Psychiatry Res. 2022 Jan;307:114334. doi: 10.1016/j.psychres.2021.114334. Epub 2021 Dec 7. Psychiatry Res. 2022. PMID: 34902818 Free PMC article.
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia.
Cuomo A, Aguglia E, Biagini S, Carano A, Clerici M, D'Agostino A, De Filippis S, De Giorgi S, Goracci A, Libri C, Lombardi F, Lupi M, Maina G, Martinotti G, Nigro P, Pettorruso M, Ricci V, Rossi E, Russo F, Fagiolini A; Italian Clinical Psychopharmacology Working Group. Cuomo A, et al. J Clin Psychopharmacol. 2023 Jan-Feb 01;43(1):35-38. doi: 10.1097/JCP.0000000000001629. J Clin Psychopharmacol. 2023. PMID: 36584247
Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study.
Monteleone P, Cascino G, Rossi A, Rocca P, Bertolino A, Aguglia E, Amore M, Andriola I, Bellomo A, Biondi M, Brasso C, Carpiniello B, Collantoni E, Dell'Osso L, di Giannantonio M, Fabrazzo M, Fagiolini A, Giordano GM, Marcatili M, Marchesi C, Monteleone AM, Pompili M, Roncone R, Siracusano A, Vita A, Zeppegno P, Galderisi S, Maj M; Italian Network for Research on Psychoses. Monteleone P, et al. Among authors: marcatili m. Schizophr Res. 2022 Oct;248:279-286. doi: 10.1016/j.schres.2022.08.015. Epub 2022 Sep 15. Schizophr Res. 2022. PMID: 36116319
Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine's fast-acting antidepressant mechanisms.
Marcatili M, Sala C, Dakanalis A, Colmegna F, D'Agostino A, Gambini O, Dell'Osso B, Benatti B, Conti L, Clerici M. Marcatili M, et al. Ther Adv Psychopharmacol. 2020 Nov 2;10:2045125320968331. doi: 10.1177/2045125320968331. eCollection 2020. Ther Adv Psychopharmacol. 2020. PMID: 33224469 Free PMC article. Review.
Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports.
Marcatili M, Borgonovo R, Cimminiello N, Cornaggia RD, Casati G, Pellicioli C, Maggioni L, Motta F, Redaelli C, Ledda L, Pozzi FE, Krivosova M, Pagano J, Nava R, Colmegna F, Dakanalis A, Caldiroli A, Capuzzi E, Benatti B, Dell'Osso B, Bertola F, Villa N, Piperno A, Ippolito S, Appollonio I, Sala C, Conti L, Clerici M. Marcatili M, et al. J Pers Med. 2022 Sep 16;12(9):1524. doi: 10.3390/jpm12091524. J Pers Med. 2022. PMID: 36143309 Free PMC article.
35 results